Position in EXEL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$54,410
+$11,520 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#618
of 751 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lummis Asset Management, LP holds $70,305 across 2 Biotechnology names. EXEL ranks #1 (77.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
1,000 | $54,410 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32 | $15,895 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,410 | 1,000 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $42,890 | 1,000 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||